Search Results - "Puig Alcaraz, N"

Donor-Specific HLA Antibodies: Risk Factors and Outcomes After Kidney Transplantation by Berga, J. Kanter, Mateu, L.M. Pallardo, Catalan, S. Beltran, Alcaraz, N. Puig, Calabuig, A. Sancho, Martinez, E. Gavela, Bernabeu, A. Avila, Albiach, J. Crespo

“…Abstract Background Anti–human leukocyte antigen antibodies (HLA Abs) have been associated with reduced kidney allograft survival. Our aim was to analyze the…”
Get full text

Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody–Low Titers by Kanter Berga, J, Sancho Calabuig, A, Gavela Martinez, E, Puig Alcaraz, N, Avila Bernabeu, A, Crespo Albiach, J, Molina Vila, P, Beltrán Catalan, S, Pallardó Mateu, L

“…Abstract Background Kidney transplantation is the better option for end-stage renal disease (ESRD), but for patients with human leukocyte antigen (HLA)…”
Get full text

Pretransplant Donor-Specific HLA Antibodies Detected by Single Antigen Bead Flow Cytometry: Risk Factors and Outcomes After Kidney Transplantation by Kanter Berga, J, Sancho Calabuig, A, Gavela Martinez, E, Puig Alcaraz, N, Beltran Catalan, S, Avila Bernabeu, A, Crespo Albiach, J, Montoro, J.A, Pallardo Mateu, L.M

“…Abstract Background The clinical significance of pretransplant donor-specific antibodies (pre-Tx DSAs) detected by single antigen bead flow cytometry (SAB-FC)…”
Get full text

Pretransplant Donor-Specific HLA Antibodies: Risk Factors and Outcomes after Kidney Transplantation: 1227 by Kanter Berga, J., Gavela Martinez, E., Puig Alcaraz, N., Sancho Calabuig, A., Pallardo Mateu, L.

Get full text

Guide for transfusion of red blood cells, platelets and labile plasma products. Joint directive of the Spanish society of blood transfusion by Algora Weber, M, Fernández Montoya, A, Gómez Villagrán, J L, Martín Vega, C, Prats Arrojo, I, Puig Alcaraz, N, Pujol Bosch, M, Vesga Carasa, M A

Get more information